https://www.selleckchem.com/pr....oducts/d-lin-mc3-dma
(interaction 2·08 [0·89-4·82; p=0·025) were not associated with cardiovascular risk. We found no evidence that testosterone increased short-term to medium-term cardiovascular risks in men with hypogonadism, but there is a paucity of data evaluating its long-term safety. Long-term data are needed to fully evaluate the safety of testosterone. National Institute for Health Research Health Technology Assessment Programme. National Institute for Health Research Health Technology Assessment Programme.[This corrects the article DOI 10.10